Prot #R668-AD-1334: A Phase 3 Confirmatory Study Investigating the Efficacy and Safety of Dupilumab Monotherapy Administered to Adult Patients With Moderate-To-Severe Atopic Dermatitis

  • Silverberg, Jonathan I (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/13/153/13/18

Funding

  • Parexel (Prot #R668-AD-1334)
  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1334)